Sign in

CIK 0001048477

  • Large accelerated filer

BIOMARIN PHARMACEUTICAL INC

Sign in to watch
Ticker
BMRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680397820
Phone
+1 415-506-6700
Business address
105 DIGITAL DRIVE, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,466,459
in 2 filings

Net −$1,466,459. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-01-27 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion +8,333 $26.49 $221K 303,885
2021-01-27 BIENAIME JEAN JACQUES Chief Executive Officer Sale −8,333 $85.49 $712K 295,552
2021-01-27 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion · Stock Option (Right to buy Common Stock) −8,333 131,180
2020-12-29 BIENAIME JEAN JACQUES Chief Executive Officer Sale −1,500 $88.18 $132K 295,552
2020-12-28 BIENAIME JEAN JACQUES Chief Executive Officer Sale −1,500 $88.77 $133K 297,052
2020-10-14 Ajer Jeffrey Robert EVP, Chief Commercial Officer Sale −2,121 $79.91 $169K 61,281
2020-10-07 HERON ELAINE J Director Exercise or conversion +15,000 $26.49 $397K 66,968
2020-10-07 HERON ELAINE J Director Exercise or conversion · Stock Option (Right to buy Common Stock) −15,000 0
2020-08-31 PYOTT DAVID E I Director Purchase +11,900 $78.22 $931K 29,840
2020-08-31 PYOTT DAVID E I Director Purchase +900 $78.84 $71K 30,740
2020-08-03 GREY MICHAEL G Director Exercise or conversion +2,500 $26.49 $66K 45,340
2020-08-03 GREY MICHAEL G Director Sale −2,500 $120.35 $301K 42,840
2020-08-03 GREY MICHAEL G Director Exercise or conversion · Stock Option (Right to buy Common Stock) −2,500 5,000
2020-07-20 FUCHS HENRY J President, Worldwide R&D Exercise or conversion +1,250 $67.81 $85K 104,245
2020-07-20 FUCHS HENRY J President, Worldwide R&D Exercise or conversion +75,716 $67.81 $5.1M 179,961
2020-07-20 FUCHS HENRY J President, Worldwide R&D Exercise or conversion +49,423 $63.10 $3.1M 229,384
2020-07-20 FUCHS HENRY J President, Worldwide R&D Sale −126,389 $130.00 $16.4M 102,995
2020-07-20 FUCHS HENRY J President, Worldwide R&D Exercise or conversion · Stock Option (Right to buy Common Stock) −1,250 0
2020-07-20 FUCHS HENRY J President, Worldwide R&D Exercise or conversion · Stock Option (Right to buy Common Stock) −75,716 0
2020-07-20 FUCHS HENRY J President, Worldwide R&D Exercise or conversion · Stock Option (Right to buy Common Stock) −49,423 0

Page 34 of 36 · 707 trades